A new study by LMU and Helmholtz Munich shows how pathogens control changes in their cell surface to evade the immune system.

VUMC received up to $30M to develop AI for antibody therapy discovery, aiming to create an antibody-antigen atlas and ...

An ambitious project led by Vanderbilt University Medical Center investigators aims to use artificial intelligence ...

Antigenic variation is a key mechanism by which pathogens evade the immune system. New research has shown how trypanosomes change their antigen expression.

Antibodies are secreted immunoglobulin molecules produced mainly by plasma cells. The antigen-binding site of the antibody has a unique structure that allows it to bind antigen in a highly ...

Vanderbilt University Medical Center has been awarded up to $30 million by the Advanced Research Projects Agency for Health ...

The global polyclonal antibody market is poised for significant expansion in the coming decade, driven by increasing ...

Ounce of Prevention is a weekly column which presents recommendations for preventative services derived from The United ...

Astrazeneca AB has synthesized antibody-drug conjugates comprising an antibody or antigen-binding fragment covalently linked to cytotoxic moieties through enzymatically cleavable linkers reported to ...

Although chimeric antigen receptor T-cell therapy has raised hopes for long-term remission in autoimmune disease, it has ...

The following is a summary of "Impact of HBsAg reduction via siRNA treatment on natural and vaccine (BRII-179)-induced ...